Nuvation Bio Inc. (NUVB-WT) Stock Overview
Explore Nuvation Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.
Nuvation Bio Inc. (NUVB-WT)
Key Financials
Key Financials
Market Cap
20.3M
P/E Ratio
-13.18
EPS (TTM)
N/A
ROE
-0.44%
NUVB-WT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nuvation Bio Inc. (NUVB-WT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.11.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.18 and a market capitalization of 20.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.